Ardena Bioanalysis B.V.

https://www.ardena.com

The Ardena Group (‘Ardena’) is a leading Contract Development and Manufacturing Organization in advanced drug development of new, innovative, and complex molecules. Ardena’s mission is to enable current and next-generation therapies to get into the clinic and to patients faster. Ardena assists pharmaceutical companies, from emerging biotechs to big pharma, in navigating through the drug discovery and development process to create effective and compliant drug substances and products for clinical trials, by providing integrated services including solid state chemistry, API, and nanomedicine drug substance development and manufacturing, analytical and formulation development, drug product manufacturing, bioanalytical and CMC regulatory services. *

	Start	2017-01-01 merged
	Group	Ardena (Group)
	Predecessor	ABL B.V. Analytisch Biochemisch Laboratorium
	Industry	contract research (drugs)
	Industry 2	analytical services

	Region	Netherlands_oo
	Country	Netherlands
	Street	7 W.A. Scholtenstraat
	City	9403 AJ Assen
	Tel	+31-592-344211
		Address record changed: 2024-06-04

Basic data	Employees	n. a.

		* Document for »About Section«: Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent.

		Record changed: 2024-06-04

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for Ardena (Group)

[1] Ardena Holding N.V.. (5/18/21). "Press Release: Investment in Flow Cytometry Unlocks the Secrets of Single Cells". Gent....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com